CAPR - Company ID 0001133869
CAPRICOR THERAPEUTICS, INC. (CAPR) reported net income of -$105.04M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$105.04M | -159.6% |
| FY 2024 | -$40.47M | -81.6% |
| FY 2023 | -$22.29M | +23.2% |
| FY 2022 | -$29.02M | -44.9% |
| FY 2021 | -$20.02M | -46.6% |
| FY 2020 | -$13.66M | -78.7% |
| FY 2019 | -$7.64M | +49.7% |
| FY 2018 | -$15.19M | -724.8% |
| FY 2017 |
CAPRICOR THERAPEUTICS, INC. (CAPR) reported net income of -$105.04M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, CAPRICOR THERAPEUTICS, INC.'s net income declined from -$1.15M to -$105.04M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $2.43M |
| +112.9% |
| FY 2016 | -$18.81M | -46.3% |
| FY 2015 | -$12.86M | -106.8% |
| FY 2014 | -$6.22M | +30.1% |
| FY 2013 | -$8.89M | -329.3% |
| FY 2012 | -$2.07M | -80.2% |
| FY 2011 | -$1.15M | - |